Back to GetFilings.com



Table of Contents



SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


     
[X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
     
For the quarterly period ended October 26, 2003 or
     
[  ]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
     

For the transition period from _________ to ______.

0-21488

(Commission File Number)


CATALYST SEMICONDUCTOR, INC.

(Exact name of Registrant as specified in its charter)


     
Delaware
(State or other jurisdiction of
incorporation or organization)
  77-0083129
(I.R.S. Employer
Identification No.)
     
1250 Borregas Avenue
Sunnyvale, California

(Address of Registrant’s principal executive offices)
  94089
(Zip Code)

(408) 542-1000

(Registrant’s telephone number, including area code)

     Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

     Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12(b)(2) of the Exchange Act). Yes o No x

     The number of shares outstanding of the Registrant’s Common Stock as of November 21, 2003 was 16,545,420 exclusive of 3,044,100 shares of treasury stock.

 


TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
PART II OTHER INFORMATION
Item 1. Legal Proceedings
Item 4. Submission of Matters to a Vote of Security Holders
Item 6. Exhibits and Reports on Form 8-K
SIGNATURES
INDEX TO EXHIBITS
EXHIBIT 31.1
EXHIBIT 31.2
EXHIBIT 32


Table of Contents

CATALYST SEMICONDUCTOR, INC.

TABLE OF CONTENTS

           
      Page
     
PART I.
FINANCIAL INFORMATION
       
Item 1.
Consolidated Financial Statements
       
 
Unaudited Condensed Consolidated Balance Sheets at October 31, 2003 and April 30, 2003
    3  
 
Unaudited Condensed Consolidated Statements of Operations for the three and six month periods ended October 31, 2003 and 2002
    4  
 
Unaudited Condensed Consolidated Statements of Cash Flows for the six month periods ended October 31, 2003 and 2002
    5  
 
Notes to Unaudited Condensed Consolidated Financial Statements
    6  
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
    13  
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
    29  
Item 4.
Controls and Procedures
    29  
PART II.
OTHER INFORMATION
       
Item 1.
Legal Proceedings
    30  
Item 4.
Submission of Matters to a Vote of Security Holder
    30  
Item 6.
Exhibits and Reports on Form 8-K
    30  
SIGNATURES
    31  
EXHIBIT INDEX
    32  
CERTIFICATIONS
       

2


Table of Contents

PART I - FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

CATALYST SEMICONDUCTOR, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)

                         
            October 31,   April 30,
            2003   2003
           
 
ASSETS
               
Current assets:
               
 
Cash and cash equivalents
  $ 4,060     $ 7,828  
 
Short term investments
    26,260       20,078  
 
Accounts receivable, net
    11,370       7,863  
 
Inventories, net
    6,234       8,423  
 
Deferred tax assets
    1,914       1,914  
 
Other assets
    792       1,146  
 
   
     
 
   
Total current assets
    50,630       47,252  
Property and equipment, net
    3,219       3,091  
Other assets
    280       245  
 
   
     
 
   
Total assets
  $ 54,129     $ 50,588  
 
   
     
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current liabilities:
               
 
Accounts payable
  $ 3,828     $ 3,674  
 
Accounts payable—related parties
    158       18  
 
Accrued expenses
    3,903       3,126  
 
Deferred gross profit on shipments to distributors
    2,098       1,417  
 
   
     
 
   
Total current liabilities
    9,987       8,235  
 
   
     
 
Commitments and Contingencies (Note 8)
               
Stockholders’ equity:
               
 
Preferred stock, $.001 par value, 2,000 shares authorized; no shares issued or outstanding
           
 
Common stock, $.001 par value, 45,000 shares authorized; 19,589 issued and 16,545 outstanding at October 31, 2003 and 19,247 shares issued and 16,285 outstanding at April 30, 2003
    20       19  
 
Additional paid in capital
    53,318       52,632  
 
Treasury stock, 3,044 at October 31, 2003 and 2,970 at April 30, 2003
    (8,555 )     (8,340 )
 
Accumulated deficit
    (640 )     (1,985 )
 
Accumulated other comprehensive income (loss)
    (1 )     27  
 
   
     
 
   
Total stockholders’ equity
    44,142       42,353  
 
   
     
 
   
Total liabilities and stockholders’ equity
  $ 54,129     $ 50,588  
 
   
     
 

See accompanying notes to the unaudited condensed consolidated financial statements.

3


Table of Contents

CATALYST SEMICONDUCTOR, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)

                                   
      Three Months Ended   Six Months Ended
     
 
      October 31,   October 31,   October 31,   October 31,
      2003   2002   2003   2002
     
 
 
 
Net revenues
  $ 15,978     $ 12,047     $ 29,825     $ 24,504  
Cost of revenues
    10,987       7,074       19,687       14,093  
 
   
     
     
     
 
Gross profit
    4,991       4,973       10,138       10,411  
Research and development
    1,650       1,194       3,198       2,484  
Selling, general and administrative
    2,924       2,523       5,531       4,882  
 
   
     
     
     
 
Income from operations
    417       1,256       1,409       3,045  
Interest income, net
    84       88       174       154  
 
   
     
     
     
 
Income before income taxes
    501       1,344       1,583       3,199  
Income tax provision
    75       501       237       1,196  
 
   
     
     
     
 
Net income
  $ 426     $ 843     $ 1,346     $ 2,003  
 
   
     
     
     
 
Net income per share:
                               
 
Basic
  $ 0.03     $ 0.05     $ 0.08     $ 0.12  
 
   
     
     
     
 
 
Diluted
  $ 0.02     $ 0.05     $ 0.07     $ 0.11  
 
   
     
     
     
 
Weighted average common shares:
                               
 
Basic
    16,483       16,739       16,421       16,833  
 
   
     
     
     
 
 
Diluted
    19,407       18,342       19,081       18,650  
 
   
     
     
     
 

See accompanying notes to the unaudited condensed consolidated financial statements.

4


Table of Contents

CATALYST SEMICONDUCTOR, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)

                         
            Six Months Ended
           
            October 31,   October 31,
            2003   2002
           
 
Cash flows from operating activities:
               
 
Net income
  $ 1,346     $ 2,003  
 
Adjustments to reconcile net income to net cash provided by operating activities:
               
   
Depreciation of property and equipment
    560       501  
   
Benefit from sale of inventory previously reserved
    (1,365 )     (1,740 )
   
Provision for excess and obsolete inventory
    594       1,730  
   
Changes in assets and liabilities:
               
     
Accounts receivable
    (3,507 )     1,202  
     
Inventories
    2,960       (136 )
     
Other assets
    319       234  
     
Accounts payable (including related parties)
    294       (982 )
     
Accrued expenses
    941       1,267  
     
Deferred gross profit on shipments to distributors
    681       (48 )
 
   
     
 
       
Net cash provided by operating activities
    2,823       4,031  
 
   
     
 
Cash flows from investing activities:
               
 
Purchase of short-term investments
    (6,210 )      
 
Acquisition of property and equipment
    (688 )     (852 )
 
   
     
 
       
Net cash used in investing activities
    (6,898 )     (852 )
 
   
     
 
Cash flows from financing activities:
               
 
Common stock issuances
    522       195  
 
Treasury stock purchases
    (215 )     (1,608 )
 
   
     
 
       
Net cash provided by (used in) financing activities
    307       (1,413 )
 
   
     
 
Net increase (decrease) in cash and cash equivalents
    (3,768 )     1,766  
Cash at beginning of the period
    7,828       26,295  
 
   
     
 
Cash at end of the period
  $ 4,060     $ 28,061  
 
   
     
 

See accompanying notes to the unaudited condensed consolidated financial statements.

5


Table of Contents

CATALYST SEMICONDUCTOR, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 1 – Basis of Presentation:

     In the opinion of the management of Catalyst Semiconductor, Inc. (Company), the unaudited condensed consolidated interim financial statements included herein have been prepared on the same basis as the April 30, 2003 audited consolidated financial statements and include all adjustments, consisting of only normal recurring adjustments, necessary to fairly state the information set forth herein. The consolidated statements include the accounts of the Company’s wholly owned subsidiaries, Nippon Catalyst KK (NCKK), a sales organization in Japan and Catalyst Semiconductor Romania SRL (CSR), a design center in Europe. All material intercompany balances have been eliminated. The statements have been prepared in accordance with the regulations of the Securities and Exchange Commission (SEC). For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended April 30, 2003. The results of operations for the three month period ended October 31, 2003 are not necessarily indicative of the results to be expected for the entire year ending April 30, 2004 or any other future period. Certain prior period balances have been reclassified to conform to the current period presentation.

     The Company’s business is highly cyclical and has been subject to significant downturns at various times which have been characterized by reduced product demand, production overcapacity and significant erosion of average selling prices.

     The Company’s fiscal year is the 52 or 53-week period ending on the Sunday closest to April 30. In a 52-week year, each fiscal quarter consists of 13 weeks. Fiscal year 2004 will be comprised of 53 weeks with the extra week added to the third quarter making it consist of 14 weeks. For presentation purposes only, the financial statements and notes refer to April 30 as the Company’s year-end and July 31, October 31 and January 31 as the Company’s quarter-ends.

     In December 2002, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards (SFAS) No. 148, “Accounting for Stock-Based Compensation, Transition and Disclosure” which amended SFAS No. 123 (SFAS 123) requiring that disclosures of the pro forma effect use the fair value method of accounting for stock-based employee compensation be displayed more prominently, in a tabular format and on a quarterly basis. The following table illustrates the effect on the Company’s net income and net income per share if compensation costs had been recorded based on the estimated fair value as of the grant date as defined by SFAS 123 for all granted stock-based awards.

                                 
    Three Months Ended   Six Months Ended
   
 
    October 31,   October 31,   October 31,   October 31,
    2003   2002   2003   2002
   
 
 
 
    (In thousands, except per share amounts)
Reported net income
  $ 426     $ 843     $ 1,346     $ 2,003  
Add: Stock-based employee compensation expense included in reported net income, net of tax
          19             47  
Deduct: Stock-based employee compensation expense determined under fair value based method for all awards, net of tax
    (673 )     (619 )     (1,421 )     (1,360 )
 
   
     
     
     
 
Pro forma net income (loss)
  $ (247 )   $ 243     $ (75 )   $ 690  
 
   
     
     
     
 
Pro forma net income per share:
                               
Basic
  $ (0.01 )   $ 0.01     $ 0.00     $ 0.04  
 
   
     
     
     
 
Diluted
  $ (0.01 )   $ 0.01     $ 0.00     $ 0.04  
 
   
     
     
     
 

6


Table of Contents

CATALYST SEMICONDUCTOR, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 2 – Net Income Per Share:

     Basic net income per share is computed by dividing net income available to common stockholders (numerator) by the weighted average number of common shares outstanding (denominator) during the period and excludes the dilutive effect of stock options. Diluted net income per share gives effect to all dilutive potential common shares outstanding during a period. In computing diluted net income per share, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options.

     A reconciliation of the numerators and denominators of the basic and diluted income per share is presented in the following table (in thousands, except per share data):

                                 
    Three Months Ended   Six Months Ended
   
 
    October 31,   October 31,   October 31,   October 31,
    2003   2002   2003   2002
   
 
 
 
Reported net income
  $ 426     $ 843     $ 1,346     $ 2,003  
 
   
     
     
     
 
Shares calculation:
                               
Weighted average shares outstanding—basic
    16,483       16,739       16,421       16,833  
Effect of dilutive securities:
                               
Stock options
    2,924       1,603       2,660       1,817  
 
   
     
     
     
 
Weighted average shares outstanding—diluted
    19,407       18,342       19,081       18,650  
 
   
     
     
     
 
Reported net income per share:
                               
Basic
  $ 0.03     $ 0.05     $ 0.08     $ 0.12  
 
   
     
     
     
 
Diluted
  $ 0.02     $ 0.05     $ 0.07     $ 0.11  
 
   
     
     
     
 

     Options to purchase 713,000 shares of common stock at a weighted average exercise price of $6.90 during the quarter ended October 31, 2003 and options to purchase 1,245,000 shares of common stock at a weighted average exercise price of $6.22 during the quarter ended October 31, 2002 were not included in the computation of diluted income per share because the inclusion of such options would have been antidilutive.

     Options to purchase 933,000 shares of common stock at a weighted average exercise price of $6.44 during the six months ended October 31, 2003 and options to purchase 1,245,000 shares of common stock at a weighted average exercise price of $6.21 during the six months ended October 31, 2002 were not included in the computation of diluted income per share because the inclusion of such options would have been antidilutive.

Note 3 – Other comprehensive Income:

     The components of other comprehensive income are presented in the following table (in thousands):

                                 
    Three Months Ended   Six Months Ended
   
 
    October 31,   October 31,   October 31,   October 31,
    2003   2002   2003   2002
   
 
 
 
Reported net income
  $ 426     $ 843     $ 1,346     $ 2,003  
Other comprehensive income:
                               
Unrealized losses on available-for-sale investments
    (21 )           (28 )      
 
   
     
     
     
 
Total other comprehensive income
  $ 405     $ 843     $ 1,318     $ 2,003  
 
   
     
     
     
 

     Accumulated other comprehensive income or expense, as presented on the accompanying condensed consolidated balance sheets, consists of the unrealized gains and loss on the available-for-sale investments.

7


Table of Contents

CATALYST SEMICONDUCTOR, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 4 – Balance Sheet Components (in thousands):